Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alz...
Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well-characterized AD and control participants, considering ophthalmological confounders.
We included 57 amyloid-proven AD cases and 85 cognitively normal, amyloid-nega...
Alternative Titles
Full title
Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4e69b77c21d94f5fa600d6f36d76c457
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e69b77c21d94f5fa600d6f36d76c457
Other Identifiers
ISSN
2352-8729
E-ISSN
2352-8729
DOI
10.1016/j.dadm.2019.05.002
